Based on ratings from 4 stock analysts, the REVOLUTION Medicines Inc stock price is expected to increase by 8.77% in 12 months. This is calculated by using the average 12-month stock price forecast for REVOLUTION Medicines Inc. The lowest target is $28.00 and the highest is $41.00. Please note analyst price targets are not guaranteed and could be missed completely.
REVOLUTION Medicines Inc has a total of 4 Wall St Analyst ratings. There are 4 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that REVOLUTION Medicines Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
robert driscoll Wedbush | Buy | $41.0 | initiatedcoverage | Jan 10, 2024 |
alec stranahan Bank of America Securities | Buy | $34.0 | upgraded | Jan 5, 2024 |
dane leone Raymond James | Buy | $30.0 | initiatedcoverage | Nov 15, 2023 |
robert burns H.C. Wainwright | Buy | $28.0 | reiterated | Nov 13, 2023 |
eric joseph J.P. Morgan | Buy | $39.0 | maintained | Nov 7, 2023 |
jonathan chang Leerink Partners | Buy | $26.0 | reiterated | Nov 6, 2023 |
marc frahm TD Cowen | Buy | None | maintained | Nov 6, 2023 |
benjamin burnett Stifel Nicolaus | Buy | $36.0 | maintained | Oct 25, 2023 |
jay olson Oppenheimer | Buy | $43.0 | rated | Oct 25, 2023 |
ami fadia Needham | Buy | $36.0 | maintained | Oct 23, 2023 |
chris shibutani Goldman Sachs | Hold | None | maintained | May 8, 2023 |
michael schmitz Ladenburg Thalmann & Co. | Buy | $38.0 | reiterated | Feb 28, 2023 |
michael schmidt Guggenheim | Buy | $38.0 | reiterated | Mar 2, 2022 |
ram selvaraju H.C. Wainwright | Buy | $55.0 | maintained | Mar 3, 2021 |
In 2023, RVMD generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that RVMD's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TMUS-USD
$161.76
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TXG-USD
$49.11